Published in World J Gastrointest Endosc on May 16, 2014
Increased chromogranin a cell density in the large intestine of patients with irritable bowel syndrome after receiving dietary guidance. Gastroenterol Res Pract (2015) 0.84
Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol (2015) 0.84
Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome. Mol Med Rep (2014) 0.83
Diet in irritable bowel syndrome. Nutr J (2015) 0.81
Effect of dietary management on the gastric endocrine cells in patients with irritable bowel syndrome. Eur J Clin Nutr (2014) 0.80
Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities. World J Gastroenterol (2015) 0.79
Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance. Exp Biol Med (Maywood) (2017) 0.76
Changes in patients' symptoms and gastric emptying after Helicobacter pylori treatment. World J Gastroenterol (2016) 0.75
Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome. Exp Ther Med (2016) 0.75
Functional bowel disorders. Gastroenterology (2006) 20.72
Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab (2001) 6.41
The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology (2007) 4.58
Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology (2004) 4.04
Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut (2007) 3.87
Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun (2000) 2.42
Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology (2003) 2.39
Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment Pharmacol Ther (1999) 2.28
Enteroendocrine cells: a site of 'taste' in gastrointestinal chemosensing. Curr Opin Endocrinol Diabetes Obes (2008) 1.94
Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol (2005) 1.93
Ghrelin stimulates gastric emptying and hunger in normal-weight humans. J Clin Endocrinol Metab (2006) 1.81
5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes (2013) 1.79
Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol (2003) 1.62
Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut (2005) 1.60
Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut (2004) 1.50
The regulation of K- and L-cell activity by GLUT2 and the calcium-sensing receptor CasR in rat small intestine. J Physiol (2012) 1.44
The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol (2008) 1.38
Taste receptors in the gastrointestinal tract. IV. Functional implications of bitter taste receptors in gastrointestinal chemosensing. Am J Physiol Gastrointest Liver Physiol (2006) 1.35
Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut (2000) 1.34
Gut chemosensing: interactions between gut endocrine cells and visceral afferents. Auton Neurosci (2009) 1.30
Serotonin release and uptake in the gastrointestinal tract. Auton Neurosci (2009) 1.28
Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection--an observation in a small case control study. Yonsei Med J (2009) 1.21
Intestinal sensing of nutrients. Handb Exp Pharmacol (2012) 1.20
Ghrelin stimulates gastric emptying but is without effect on acid secretion and gastric endocrine cells. Regul Pept (2004) 1.18
Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome. Scand J Gastroenterol (2010) 1.17
Endogenous acyl ghrelin is involved in mediating spontaneous phase III-like contractions of the rat stomach. Neurogastroenterol Motil (2007) 1.12
Serotonin is a sword and a shield of the bowel: serotonin plays offense and defense. Trans Am Clin Climatol Assoc (2012) 1.09
Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome. Neurogastroenterol Motil (2006) 1.08
Abnormal rectal endocrine cells in patients with irritable bowel syndrome. Regul Pept (2013) 1.07
Evaluation of the Birmingham IBS symptom questionnaire. BMC Gastroenterol (2008) 1.06
Plasticity in serotonin control mechanisms in the gut. Curr Opin Pharmacol (2003) 1.05
Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome. World J Gastroenterol (2007) 1.05
Actions of 5-hydroxytryptamine on myenteric neurons in guinea pig gastric antrum. Am J Physiol (1992) 1.02
Ghrelin stimulates motility in the small intestine of rats through intrinsic cholinergic neurons. Regul Pept (2004) 1.01
Nutrient sensing in the gastrointestinal tract: possible role for nutrient transporters. J Physiol Biochem (2008) 1.01
Is irritable bowel syndrome an organic disorder? World J Gastroenterol (2014) 1.01
Relative importance of abnormalities of CCK and 5-HT (serotonin) in Giardia-induced post-infectious irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther (2010) 1.00
Irritable bowel syndrome: the role of gut neuroendocrine peptides. Front Biosci (Elite Ed) (2012) 0.98
5-HT receptor subtypes outside the central nervous system. Roles in the physiology of the gut. Neuropsychopharmacology (1991) 0.98
Ghrelin enhances gastric motility through direct stimulation of intrinsic neural pathways and capsaicin-sensitive afferent neurones in rats. Scand J Gastroenterol (2004) 0.98
Enteroendocrine cells: neglected players in gastrointestinal disorders? Therap Adv Gastroenterol (2008) 0.98
The role of diet in the pathogenesis and management of irritable bowel syndrome (Review). Int J Mol Med (2012) 0.97
Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome. Dig Dis Sci (2010) 0.96
Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome. Dig Dis Sci (2011) 0.96
Subpopulations of gastric myenteric neurons are differentially activated via distinct serotonin receptors: projection, neurochemical coding, and functional implications. J Neurosci (1997) 0.95
Ghrelin in gastrointestinal diseases and disorders: a possible role in the pathophysiology and clinical implications (review). Int J Mol Med (2009) 0.95
Ghrelin and the regulation of food intake and energy balance. Mol Interv (2002) 0.95
Nutrient sensing in the gut: interactions between chemosensory cells, visceral afferents and the secretion of satiation peptides. Physiol Behav (2011) 0.95
Endocrine cells in the ileum of patients with irritable bowel syndrome. World J Gastroenterol (2014) 0.93
Ghrelin-induced stimulation of colonic propulsion is dependent on hypothalamic neuropeptide Y1- and corticotrophin-releasing factor 1 receptor activation. J Neuroendocrinol (2005) 0.92
Chromogranin A cell density in the rectum of patients with irritable bowel syndrome. Mol Med Rep (2012) 0.92
Ghrelin in patients with irritable bowel syndrome. Int J Mol Med (2009) 0.88
Ghrelin accelerates gastric emptying via early manifestation of antro-pyloric coordination in conscious rats. Regul Pept (2007) 0.87
Luminal chemosensing in the duodenal mucosa. Acta Physiol (Oxf) (2011) 0.87
Effect of ghrelin on gastric myoelectric activity and gastric emptying in rats. Regul Pept (2007) 0.85
Ghrelin and the brain-gut axis as a pharmacological target for appetite control. Curr Pharm Des (2012) 0.82
Luminal amino acid-sensing cells in gastric mucosa. Digestion (2011) 0.81
Ghrelin family of peptides and gut motility. J Gastroenterol Hepatol (2011) 0.79
Is irritable bowel syndrome an organic disorder? World J Gastroenterol (2014) 1.01